While anti-VEGF therapies have had a remarkable impact on the treatment of both PDR and DME, not all patients respond adequately despite monthly treatment, highlighting the importance of identifying new therapies for the prevention or treatment of diabetic eye disease. Here, VEGFA is linked to diabetic eye disease.